Logo of Arabian International Healthcare Holding Co.
Alaa Ahmed Abdul Majeed Ameen, Chief Executive Officer (CEO) of Arabian International Healthcare Holding Co. (Tibbiyah), said the approval of the Capital Market Authority (CMA) on the company's request to register its shares and offer five million shares on the Parallel Market (Nomu) represents the beginning of an important stage in the history and journey of the company.
Tibbiyah has a track record of achievements in implementing major healthcare projects in the Kingdom; providing support services logistics and supply chains with high efficiency; and being the strategic partner of choice for customers and the largest global suppliers, Ameen said in statement.
The company succeeded in concluding and implementing many projects in the healthcare sector with the Ministry of Health and other government healthcare service providers, public and private hospitals, and medical centres, through its strong relationships with more than 400 foreign and local suppliers, providing all the needs of hospitals, medical centres, polyclinics, and clinics throughout the Kingdom.
Ameen pointed out that Tibbiyah, through its main arms: Alfaisaliah Medical Systems, International Medical Supplies, in addition to its joint venture with Philips, succeeded in achieving many milestones within the healthcare sector in the Kingdom, thanks to its solid base of medical cadres, technical and professional expertise that enabled it to move forward in implementing its development and expansion plans, which was reflected in the exceptional financial performance of the company during the past years, and the relentless endeavour to maintain this performance in the future.
On the other hand, Chairman Ziad Muhammad Makki Saleh Altunisi said Tibbiyah – a subsidiary of AlFaisaliah Holding Group, and its active arm in the field of healthcare services - is one of the leading companies in providing integrated healthcare solutions in the Kingdom, and since the establishment of its first company in Riyadh in 1973, has been proceeding with confident steps in implementing its strategy aimed at contributing to the improvement of the health and life of the population of the Kingdom by providing pioneering and innovative healthcare solutions.
The company focused on three main foundations; promoting and the development of its leading position in the field of integrated healthcare solutions; supporting the transformation strategy for the healthcare sector in the Kingdom in line with Vision 2030 through active participation in public-private partnership initiatives and the provision of related support services, in addition to contributing to maximizing the percentage of localization of industries and services within the sector; and investment in the field of healthcare services and technology, including, for example, centres specialized in the fields of oncology, radiological diagnosis, medical laboratories, in addition to day operations centres.
On Dec. 29, 2021, the CMA approved the offering of 25% of Tibbiyah on Nomu. The offering will be limited to qualified investor categories. They are set out in the Glossary of Terms Used in the Regulations and Rules of the CMA.
The planned offering in the parallel market will be divided into two tranches:
The first tranche: Qualified investors (non-individuals), where 100% of the shares will be initially allocated to them, provided that the final allocation is after the end of the subscription period for qualified investors (individuals), where the percentage
allocated to them can be reduced, based on what the financial advisor deems to be the offering in coordination with the company, to 80% of the offered shares, equivalent to a minimum of four million shares of the offer shares.
The second tranche: Qualified investors (individuals), where 20% of the shares will be allocated to them, equivalent to one million shares.
Qualified investors (individuals) are defined as natural persons who may open an investment account in the Kingdom and an account with the Depository Centre.
Those investors are required to have executed deals in securities markets, with a total value of not less than SAR 40 million, and not less than 10 deals in each quarter during the past 12 months; have net asset value of no less than SAR 5 million; have been working or have for at least three years in the financial sector; holds a general certificate in securities dealing, approved by CMA; holds a professional certificate in the field of securities business, approved by an internationally recognized body.
The following is the offering main dates:
Event |
Dates |
Book-Building for Qualified Investors (Non-Individuals) |
From Jan. 30-Feb. 3 |
Subscription for Qualified Investors (Non-Individuals) |
From Feb. 9-14 |
Offering Period for Qualified Investors (Individuals) |
From Feb. 15-17 |
Deadline for Qualified Investors (Non-Individuals) to submit Subscription applications based on the provisional allocation |
Feb. 14 |
Deadline for Qualified Investors (Individuals) to submit Subscription applications |
Feb. 17 |
Announcement of Final Offer Shares Allocation and Notifying Investors |
Feb. 21 |
Refund of Excess Subscription amounts (if any) |
Feb. 23 |
Expected Start Date of Trading |
To be determined later. An announcement of the commencement of trading of the shares will be made on the local newspapers and on Saudi Tadawul’s website: www.saudiexchange.sa |
For more information and details related to the subscription, please refer to the Red Herring Prospectus published on the website of:
- Arabian International Healthcare Holding Company “TIBBIYAH”
- The Financial Advisor and Lead Book Runner “Aldukheil Financial Group”
- The Capital Market Authority
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}